Evidence map›Paper›PMID 26690878›Full record

ArticleChembiochem : a European journal of chemical biology2016

Mutating a Highly Conserved Residue in Diverse Cytochrome P450s Facilitates Diastereoselective Olefin Cyclopropanation.

Joshua G Gober, Amy E Rydeen, Evan J Gibson-O'Grady, Janelle B Leuthaeuser, Jacquelyn S Fetrow, Eric M Brustad

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Engineered Myoglobin Catalysts for Asymmetric Intermolecular Cyclopropanation Reactions.Bulletin of Japan Society of Coordination Chemistry · 2022
    Article
  7. Review
  8. Unlocking the therapeutic potential of artificial metalloenzymes.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Catalytic iron-carbene intermediate revealed in a cytochromeProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  19. An Artificial Heme Enzyme for Cyclopropanation Reactions.Angewandte Chemie (International ed. in English) · 2018
    Article
  20. Asymmetric Reductive Carbocyclization Using Engineered Ene Reductases.Angewandte Chemie (International ed. in English) · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Joshua G GoberDepartment of Chemistry, University of North Carolina at Chapel Hill, 125 South Rd CB 3290, Chapel Hill, NC, 27599-3290, USA.
Amy E RydeenDepartment of Chemistry, University of North Carolina at Chapel Hill, 125 South Rd CB 3290, Chapel Hill, NC, 27599-3290, USA.
Evan J Gibson-O'GradyDepartment of Chemistry, University of North Carolina at Chapel Hill, 125 South Rd CB 3290, Chapel Hill, NC, 27599-3290, USA.
Janelle B LeuthaeuserDepartment of Molecular Genetics and Genomics, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157, USA.
Jacquelyn S FetrowDepartment of Chemistry, Gottwald Center for the Sciences, University of Richmond, 28 Westhampton Way, Richmond, VA, 23173, USA.
Eric M BrustadDepartment of Chemistry, University of North Carolina at Chapel Hill, 125 South Rd CB 3290, Chapel Hill, NC, 27599-3290, USA. brustad@email.unc.edu.
University of North Carolina at Chapel Hill · USUniversity of Richmond · USWake Forest University · US

Funding

Structural and Computational Biophysics Training ProgramT32GM095440 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HOLLIS, THOMAS J, LYLES, DOUGLAS S. · 2011 to 2020
$1.7M
NIGMS NIH HHS T32 GM095440
6 · The paper itself

Abstract

Cytochrome P450s and other heme-containing proteins have recently been shown to have promiscuous activity for the cyclopropanation of olefins using diazoacetate reagents. Despite the progress made thus far, engineering selective catalysts for all possible stereoisomers for the cyclopropanation reaction remains a considerable challenge. Previous investigations of a model P450 (P450BM3 ) revealed that mutation of a conserved active site threonine (Thr268) to alanine transformed the enzyme into a highly active and selective cyclopropanation catalyst. By incorporating this mutation into a diverse panel of P450 scaffolds, we were able to quickly identify enantioselective catalysts for all possible diastereomers in the model reaction of styrene with ethyl diazoacetate. Some alanine variants exhibited selectivities that were markedly different from the wild-type enzyme, with a few possessing moderate to high diastereoselectivity and enantioselectivities up to 97 % for synthetically challenging cis-cyclopropane diastereomers.

Indexed as

Conserved SequenceMutationAlkenesCatalytic DomainCyclopropanesCytochrome P-450 Enzyme SystemStereoisomerismAlkenescyclopropaneCyclopropanesCytochrome P-450 Enzyme Systembiocatalysiscyclopropanationcytochromesprotein engineering

Identifiers

PMID26690878
PMCPMC5241096
OpenAlexW2210228437

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.